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p38, p44 / p42, and stress-activated protein 
kinase / c-Jun N-terminal kinase; the Janus 
kinase / signal transducer and activator of 
transcription pathway; and the protein 
kinase C pathway. Signal transduction 
leads to downstream consequences 
including generation of reactive oxygen 
species and activation of transcription fac-
tors such as nuclear factor-  B. AGE –
 RAGE induction of nuclear factor-  B or 
other pathways contributes to the release 
of proinfl ammatory cytokines, and the 
expression of adhesion molecules and 
growth factors such as transforming 
growth factor-  1, vascular endothelial 
growth factor, connective tissue growth 
factor, interleukins-1  and -6, insulin-like 
growth factor-1, platelet-derived growth 
factor, tumor necrosis factor-  , and vas-
cular cell adhesion molecule-1. 1 Infl am-
matory cells such as monocytes / 
macrophages induced by proinfl amma-
tory cytokines may also contribute to the 
renal damage at a later stage of kidney dis-
ease in obesity. Further study is required 
( Figure 1 ). 
 Harcourt  et al. 10 provide evidence to 
support the mechanism responsible for 
AGE – RAGE interaction and their down-
stream oxidative stress and infl amma-
tion in obesity-related dysfunction. It is 
notable that a low-AGE diet improved 
renal function in healthy obese individu-
als in a short period (2 weeks). RAGE is 
a multiligand receptor for AGEs that rec-
ognize a common motif. Similarly, the 
eff ects of AGEs are also mediated via 
several receptors, including RAGE, 
AGE-R1, AGE-R2, AGE-R3, CD36, 
ezrin, radixin, and moesin proteins. 1 
Th erefore, until the physiological prop-
erties of RAGE are clearly understood, it 
is best to adopt a cautious approach when 
future therapeutic strategies involving 
long-term blockade of RAGE or its lig-
ands are considered. 
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 Cystic kidney disease is the most frequent 
genetic cause of end-stage renal disease. 1 
Autosomal dominant polycystic kidney 
disease (ADPKD), the most common 
form of cystic renal disease, results from 
mutations in the genes polycystic kidney 
disease 1 ( PKD1 ) and  PKD2 , which 
encode polycystin-1 (PC-1), a large trans-
membrane protein, and PC-2, a cation 
channel. In ADPKD, new cysts develop 
progressively throughout life, ultimately 
resulting in end-stage renal disease. Th is 
phenotype combined with a dominant 
mode of inheritance has prompted the 
proposal of a  ‘ second-hit ’ hypothesis, 
which suggests that an inherited germline 
mutation combined with a second spon-
taneous somatic mutation results in a 
recessive gene defect on the cellular level. 
Th is in turn may promote clonal expan-
sion of cells, similarly to the two-hit model 
in cancer progression. Parallels between 
cancer progression and cyst development 
also prompted the idea of an involvement 
of the oncogenic WNT /  -catenin signal-
ing pathway in cystic kidney disease. 
 Th e WNT family of secreted glycopro-
teins plays important roles in the control 
of embryonic development and tissue 
regeneration. 2,3 Th e core component of 
the canonical WNT pathway is the 
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 Cystic kidney diseases have been linked to defective WNT signal 
transduction. Perturbations of cystic disease genes cause activation of 
canonical WNT /  -catenin / TCF / Lef1 signaling in model organisms and 
cultured cells. Inappropriate levels of WNT /  -catenin signaling cause 
renal cyst formation in mice. These observations have prompted the 
idea  that an activation of WNT /  -catenin signaling may constitute a 
common causative event in cyst formation. Now this view is challenged 
by key genetic mouse models of cystic kidney disease that do not 
display WNT /  -catenin activity in cyst-lining epithelia. 
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 protein   -catenin, which is controlled by 
extracellular WNT signals and, when 
activated, cooperates with T-cell factor 
(TCF) / Lef1 transcription factors to 
induce the expression of WNT target 
genes. In the absence of a WNT signal, 
cytoplasmic   -catenin is continuously 
phosphorylated by a multiprotein 
destruction complex in the cytoplasm, 
which includes axin, adenomatous poly-
posis coli (APC), and glycogen synthase 
kinase 3  (GSK3b). Phosphorylated   -
catenin is targeted for proteasomal deg-
radation. Binding of WNTs to their 
receptors, Frizzled proteins, and the con-
secutive recruitment of the protein 
Dishevelled lead to an inactivation of the 
destruction complex, which in turn pro-
motes   -catenin accumulation and trans-
location to the nucleus.    -Catenin 
displaces the transcriptional repressor 
Groucho from the TCF / Lef eff ector com-
plex and recruits a number of coactiva-
tors to regulate the expression of target 
genes. Among these target genes are cell-
proliferation factors and proto-oncogenes 
(for example,  c-Myc ) as well as compo-
nents of the WNT pathway itself (for 
example,  Axin2 ). 
 Alternative WNT signaling cascades are 
known. Most notably, WNT signals can 
regulate epithelial-cell polarity across a 
sheet or tube, a process termed planar cell 
polarity (PCP). 4 Th e WNT / PCP pathway, 
like the WNT /  -catenin pathway, involves 
Frizzled receptors and Dishevelled, but the 
downstream cascade diff ers in that it is 
independent of   -catenin stabilization and 
TCF / Lef1 transcription factors. Instead, 
WNT / PCP signaling activates the 
GTPases Rho and Rac as well as Jun 
N-terminal kinase (JNK). 
 A role for WNT signaling in polycystic 
kidney disease was fi rst proposed by Kim, 
Walz, and colleagues in 1999, on the basis 
of the observation that the C-terminal cyto-
plasmic domain of PC-1, when overex-
pressed in a cell line (HEK293), stabilized 
  -catenin and induced the transcription of 
a TCF / Lef1-dependent reporter. 5 In addi-
tion, overexpression of the same PC-1 frag-
ment in zebrafi sh induced dorsalization, a 
readout compatible with an ectopic induc-
tion of canonical WNT signaling. Eventu-
ally, it was reported that transgenic mice 
expressing a stabilized mutant of   -catenin 
in renal tubules developed progressive kid-
ney cysts aft er birth. 6 Similarly, cyst forma-
tion was observed in mice with a kidney 
tubule-specifi c defi ciency of APC, which 
also resulted in tubular activation of   -cat-
enin signaling. 7 On the basis of these stud-
ies, it was concluded that polycystin has the 
capacity to modulate WNT /  -catenin sig-
naling and that ectopic WNT /  -catenin 
signaling in tubules was suffi  cient to induce 
cyst formation. 
 It also became apparent that non-motile 
primary cilia, organelles that extend from 
renal epithelial cells into the tubular 
lumen, play a central role in cystic kidney 
disease. Several causative genes in mouse 
models of cystic kidney diseases, including 
 PKD1 and  PKD2 , were reported to encode 
ciliary proteins. 8,9 Simons  et al. , in a land-
mark paper, proposed that inversin, a cili-
ary protein mutated in nephronophthisis 
type II, an autosomal recessive cystic 
kidney disease, acts as a molecular switch 
between the WNT /   -catenin and 
WNT / PCP signaling cascades. 10 They 
found that inversin inhibits   -catenin /
 TCF / Lef1 signaling and promotes degra-
dation of Dishevelled in HEK293 cells. 
They also observed that inversin was 
required for convergent extension move-
ments in  Xenopus laevis , a readout typical 
of PCP signaling. Together these observa-
tions suggested that inversin changed the 
balance between WNT signaling cascades 
in favor of PCP signaling and that its 
mutation resulted in exaggerated   -cat-
enin signaling, ultimately promoting 
cystogenesis ( Figure 1 ). Simons  et al. also 
proposed that the onset of urinary fl ow 
during nephrogenesis may be transmitted 
via cilia in order to turn off canonical 
WNT and initiate WNT / PCP signaling. 
Th is was based on experiments using a 
cultured collecting duct cell line (IMCD3) 
that responded to fl ow with an increased 
expression of inversin and a decreased 
level of   -catenin. Th e concept of cilia-
mediated inhibition of WNT /  -catenin 
signaling was further supported by experi-
ments in HEK293 cells revealing that knock-
down of different ciliary proteins and 
perturbation of ciliary assembly and main-
tenance led to increased WNT /  -catenin 
activity and responsiveness. 11 
 Although these studies elegantly 
provided evidence for a modulation of 
WNT /  -catenin signaling by ciliary 
proteins in cell-culture systems or 
non-mammalian model organisms, they 
did not examine whether the mutation of 
the genes encoding these proteins led to 
ectopic activation of WNT /  -catenin 
signaling in the kidney during cyst forma-
tion, nor did they provide evidence for a 
necessary role for WNT /  -catenin signal-
ing in cyst formation. In fact, there was 
evidence that cystic kidney disease was 
not universally dependent on WNT /  -
catenin signaling. Carroll ’ s group gener-
ated mice with a conditional knockout of 
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 Figure 1  |  The controversial role of WNT signaling pathways in cystogenesis. BBS, Bardet-Biedl 
syndrome. 
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WNT9B in the diff erentiated regions of 
developing collecting ducts. 12 Th ese mice 
developed kidney cysts during embryo-
genesis and died within the fi rst weeks of 
life. A detailed analysis of cystogenesis in 
these mice suggested that, during early 
kidney development, convergent exten-
sion movements in the renal tubule were 
perturbed, and that postnatally the orien-
tation of cell division along the tubular 
axis was disrupted. In addition, the study 
reported molecular evidence for a reduc-
tion of Rho / JNK signaling in the WNT9B-
defi cient kidneys. Together, these data 
were highly suggestive of compromised 
WNT / PCP signaling in these mice. In 
contrast, there was no alteration of   -cat-
enin activation in WNT9B-defi cient kid-
ney extracts and no evidence of ectopic 
expression of the WNT /  -catenin target 
gene  Axin2 in the cyst walls. Furthermore, 
haploinsuffi  ciency of   -catenin did not 
ameliorate cyst formation in this model, 
suggesting that the dose of   -catenin sig-
naling was not a relevant pathophysiolog-
ical determinant of cyst formation in this 
model. Hence, in the WNT9B-defi cient 
mouse model of cystic kidney disease, 
there was no evidence of a WNT /  -
catenin signaling defect. 
 Miller  et al. 13 (this issue) aimed to fur-
ther characterize WNT /  -catenin signal-
ing during the establishment of urinary 
fl ow in the developing kidney and in cystic 
kidney disease. First, the authors found 
that primary cilia were fi rst present on the 
epithelial cells of the ureteric bud, the pre-
cursor to the collecting ducts, on embry-
onic day 15.5, and that urinary fl ow was 
fi rst established around the same time. 
Th ey then used TCF / Lef1- lacZ transgenic 
mice that express   -galactosidase under 
the control of six TCF / Lef response ele-
ments, thereby enabling spatial resolution 
of TCF / Lef1-mediated transcription 
 in vivo . Th ey found that the   -catenin sig-
naling was downregulated in a close tem-
poral relationship with the onset of 
urinary fl ow, supporting Simons  et al. ’ s 
concept of fl ow / cilia-mediated downregu-
lation of   -catenin signaling. Next, they 
bred the TCF / Lef1-LacZ mice with two 
independent mouse models of ADPKD, 
PKD-1-null mutants and PKD-2 / WS25 
mice. PKD-1-null mutants develop severe 
polycystic kidney disease during embryo-
genesis and die perinatally, whereas PKD-
2 / WS25 mice display a later onset of 
polycystic kidney disease, allowing exam-
ination of adult cystic kidneys. Surpris-
ingly, while the authors detected the 
known pattern of   -catenin / TCF / Lef1 
activity during kidney development in 
these mice, 14,15 they did not fi nd evidence 
of TCF / Lef1 activity in cyst-lining cells. 
Th ey also performed immunoblots for 
active unphosphorylated   -catenin in the 
ADPKD kidneys before birth and aft er 
completion of nephrogenesis and found 
no diff erences. Th ese data are in contrast 
to results from Kim  et al. , 16 who reported 
signifi cantly increased   -catenin, Axin2, 
and c-Myc staining in cystic kidneys from 
mice with a conditional inactivation of 
PKD-2. In yet another study that was 
recently reported in  Kidney Interna-
tional , 17 inversin mutant mice, which 
develop severe cystic kidney disease dur-
ing late embryogenesis and perinatally, 
were mated to a distinct strain of TCF / Lef 
reporter mice. Th e results were similar to 
those of Miller  et al. : 13 reporter activity in 
inversin knockout kidneys was restricted 
to the nephrogenic zone, and no reporter 
activity was observed in cyst-lining epi-
thelia. Likewise, no evidence of   -catenin 
activation was found in these kidneys. 
 Th ese studies challenge the model of 
dysregulated   -catenin signaling as a uni-
fying theme in polycystic kidney disease. 
It is noteworthy that there is an ongoing 
debate about the utility of the currently 
available WNT reporter mice, including the 
TCF / Lef-LacZ mice used by Miller  et al. 13 Th e 
absence of reporter activation in these mice 
does not generally exclude the presence of 
WNT /  -catenin signaling, as these reporters 
are context-dependent. 18 Importantly, several 
instances have been reported in which trans-
genic TCF reporters failed to label sites of 
known canonical WNT signaling. 19 In addi-
tion, the absence of the reporter in developed 
cysts does not exclude a transient phase of 
WNT activity during cyst development, 
which may have been missed in these studies. 
Hence, the fi nal call on the role of   -catenin 
signaling is yet to be made. 
 Future studies should aim toward dis-
secting  in vivo the functional role of 
  -catenin and other canonical WNT com-
ponents in cystogenesis. If WNT /  -cat-
enin signaling is not as important as 
previously thought, what is the alternative 
pathway in cyst formation? On the basis 
of most currently available evidence, it 
appears that many types of renal cystic 
diseases can be explained by PCP signal-
ing defects. Th e apparent contradiction 
between this idea and the observation 
that cysts develop following stabilization 
of   -catenin in kidney tubules could be 
explained by cross-talk between the WNT 
signaling pathways. Gerdes  et al. 11 
reported that a mild stimulation of canon-
ical WNT signaling in zebrafi sh induced 
a convergent extension defect compatible 
with inhibited PCP signaling. Hence, if 
  -catenin stabilization in kidney tubules 
is operative in certain types of cystic kid-
ney diseases, it may induce a secondary 
WNT / PCP defect that in turn accounts 
for cyst formation. In sum, the role of 
  -catenin as a mediator of polycystic kid-
ney disease is in question, and additional 
functional studies are needed to explore 
this possibility in more detail. 
 DISCLOSURE 
 The authors declared no competing interests. 
 ACKNOWLEDGMENTS 
 Kai M. Schmidt-Ott is supported by grants 
from the Deutsche Forschungsgemeinschaft 
(Schm1730 / 2-1 and Schm1730 / 3-1). 
 REFERENCES 
 1 .  Harris  PC ,  Torres  VE .  Polycystic kidney disease . 
 Annu Rev Med  2009 ;  60 :  321 – 337 . 
 2 .  Grigoryan  T ,  Wend  P ,  Klaus  A  et al.  Deciphering the 
function of canonical WNT signals in development 
and disease: conditional loss- and gain-of-
function mutations of beta-catenin in mice .  Genes 
Dev  2008 ;  22 :  2308 – 2341 . 
 3 .  Schmidt-Ott  KM ,  Barasch  J .  WNT/beta-catenin 
signaling in nephron progenitors and their 
epithelial progeny .  Kidney Int  2008 ;  74 :  
1004 – 1008 . 
 4 .  Seifert  JR ,  Mlodzik  M .  Frizzled/PCP signalling: a 
conserved mechanism regulating cell polarity and 
directed motility .  Nat Rev  2007 ;  8 :  126 – 138 . 
 5 .  Kim  E ,  Arnould  T ,  Sellin  LK  et al.  The polycystic 
kidney disease 1 gene product modulates WNT 
signaling .  J Biol Chem  1999 ;  274 :  4947 – 4953 . 
 6 .  Saadi-Kheddouci  S ,  Berrebi  D ,  Romagnolo  B  et al. 
 Early development of polycystic kidney disease in 
transgenic mice expressing an activated mutant 
of the beta-catenin gene .  Oncogene  2001 ;  20 : 
 5972 – 5981 . 
 7 .  Qian  CN ,  Knol  J ,  Igarashi  P  et al.  Cystic renal 
neoplasia following conditional inactivation of 
Apc in mouse renal tubular epithelium .  J Biol Chem 
 2005 ;  280 :  3938 – 3945 . 
 8 .  Otto  EA ,  Schermer  B ,  Obara  T  et al.  Mutations in 
INVS encoding inversin cause nephronophthisis 
type 2, linking renal cystic disease to the function 
of primary cilia and left-right axis determination . 
 Nat Genet  2003 ;  34 :  413 – 420 . 
commentar y
138   Kidney International (2011) 80 
 9 .  Yoder  BK ,  Hou  X ,  Guay-Woodford  LM .  The 
polycystic kidney disease proteins, polycystin-1, 
polycystin-2, polaris, and cystin, are co-localized in 
renal cilia .  J Am Soc Nephrol  2002 ;  13 :  2508 – 2516 . 
 10 .  Simons  M ,  Gloy  J ,  Ganner  A  et al.  Inversin, the gene 
product mutated in nephronophthisis 
type II, functions as a molecular switch between 
WNT signaling pathways .  Nat Genet  2005 ;  37 : 
 537 – 543 . 
 11 .  Gerdes  JM ,  Liu  Y ,  Zaghloul  NA  et al.  Disruption 
of the basal body compromises proteasomal 
function and perturbs intracellular WNT response . 
 Nat Genet  2007 ;  39 :  1350 – 1360 . 
 12 .  Karner  CM ,  Chirumamilla  R ,  Aoki  S  et al.  Wnt9b 
signaling regulates planar cell polarity and kidney 
tubule morphogenesis .  Nat Genet  2009 ;  41 : 
 793 – 799 . 
 13 .  Miller  MM ,  Iglesias  DM ,  Zhang  Z  et al.  T-cell 
factor/  -catenin activity is suppressed in two 
different models of autosomal dominant 
polycystic kidney disease .  Kidney Int  2011 ;  80 :  
146 – 153 . 
 14 .  Iglesias  DM ,  Hueber  PA ,  Chu  L  et al.  Canonical 
WNT signaling during kidney development .  
 Am J Physiol Renal Physiol  2007 ;  293 :  F494 – F500 . 
 15 .  Schmidt-Ott  KM ,  Masckauchan  TN ,  Chen  X  et 
al.   -Catenin/TCF/Lef controls a differentiation-
associated transcriptional program in renal 
epithelial progenitors .  Development  2007 ;  134 : 
 3177 – 3190 . 
 16 .  Kim  I ,  Ding  T ,  Fu  Y  et al.  Conditional mutation 
of Pkd2 causes cystogenesis and upregulates 
beta-catenin .  J Am Soc Nephrol  2009 ;  20 :  
2556 – 2569 . 
 17 .  Sugiyama  N ,  Tsukiyama  T ,  Yamaguchi  TP  et al.  
 The canonical WNT signaling pathway is not 
involved in renal cyst development in the 
kidneys of  inv mutant mice .  Kidney Int  2011 ;  79 : 
 957 – 965 . 
 18 .  Barolo  S .  Transgenic WNT/TCF pathway 
reporters: all you need is Lef?  Oncogene  2006 ;  25 : 
 7505 – 7511 . 
 19 .  Geng  X ,  Xiao  L ,  Lin  GF  et al.  Lef/Tcf-dependent 
WNT/beta-catenin signaling during Xenopus axis 
specification .  FEBS Lett  2003 ;  547 :  1 – 6 . 
